Evidence map›Paper›PMID 36560630›Full record

Observational studyViruses2022

Rildo: Real-World Multicenter Study on the Effectiveness and Safety of Single-Tablet Regimen of Dolutegravir plus Rilpivirine in Treatment-Experienced People Living with HIV.

Carmen Hidalgo-Tenorio, David Vinuesa, Coral García-Vallecillos, Leopoldo Muñoz-Medina, Sergio Sequera, Rosario Javier, Miguel Ángel López-Ruz, Svetlana Sadyrbaeva-Dolgova, Juan Pasquau

Open access · goldAbstract readObservational StudyMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Viruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Carmen Hidalgo-TenorioUnit of Infectious Diseases, Virgen de las Nieves University Hospital, Biohealth Research Institute, IBS-Granada, 18014 Granada, Spain.ORCID 0000-0002-6394-5728
David VinuesaUnit of Infectious Diseases, San Cecilio University Hospital, Biohealth Research Institute, IBS-Granada, 18012 Granada, Spain.
Coral García-VallecillosUnit of Infectious Diseases, Virgen de las Nieves University Hospital, Biohealth Research Institute, IBS-Granada, 18014 Granada, Spain.
Leopoldo Muñoz-MedinaUnit of Infectious Diseases, San Cecilio University Hospital, Biohealth Research Institute, IBS-Granada, 18012 Granada, Spain.
Sergio SequeraUnit of Infectious Diseases, Virgen de las Nieves University Hospital, Biohealth Research Institute, IBS-Granada, 18014 Granada, Spain.
Rosario JavierUnit of Infectious Diseases, Virgen de las Nieves University Hospital, Biohealth Research Institute, IBS-Granada, 18014 Granada, Spain.
Miguel Ángel López-RuzUnit of Infectious Diseases, Virgen de las Nieves University Hospital, Biohealth Research Institute, IBS-Granada, 18014 Granada, Spain.ORCID 0000-0002-1671-4281
Svetlana Sadyrbaeva-DolgovaUnit of Infectious Diseases, Virgen de las Nieves University Hospital, Biohealth Research Institute, IBS-Granada, 18014 Granada, Spain.
Juan PasquauUnit of Infectious Diseases, Virgen de las Nieves University Hospital, Biohealth Research Institute, IBS-Granada, 18014 Granada, Spain.
Instituto de Investigación Biosanitaria de Granada · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two-drug regimens (2DRs) are emerging in clinical practice guidelines as treatment option for both naive and treatment-experienced people living with HIV (PLHIV).

Indexed as

Anti-HIV AgentsHIV InfectionsDolutegravirFemaleHeterocyclic Compounds, 3-RingHumansLipidsMaleMiddle AgedRilpivirineTabletsViral LoadAnti-HIV AgentsDolutegravirHeterocyclic Compounds, 3-RingLipidsRilpivirineTablets2DRdolutegravirrilpivirinetreatment-experienced PLHIV

Identifiers

PMID36560630
PMCPMC9780933
OpenAlexW4310036478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.